Agilent Technologies Inc.
Compare this stock
A Stock Report Card
$
67%
Performance
Score:
29/100
A returned -20.34% in the last 12 months. Based on SPY's performance of -16.79%, its performance is below average giving it a score of 28 of 100.
Analyst Price Targets
Score:
82/100
14 analysts offer 12-month price targets for A. Together, they have an average target of 167.75, the most optimistic target put A at 170 within 12-months and the most pessimistic has A at 161.
Sentiment
Score:
69/100
A had a bullish sentiment score of 69.50% across Twitter and StockTwits over the last 12 months. It had an average of 77.66 posts, 409.66 comments, and 1,364.19 likes per day.
Technicals
Score:
50/100
A receives a 50 of 100 based on 14 indicators. 6 are bullish, 6 are bearish.
Earnings
Score:
100/100
A has missed earnings 0 times in the last 20 quarters.
Profit
Score:
79/100
Out of the last 20 quarters, A has had 20 profitable quarters and has increased their profits year over year on 10 of them.
Volatility
Score:
52/100
A has had a higher than average amount of volatility over the last 12 months giving it a score of 51 of 100.
Dividend
Score:
48/100
A's most recent dividend was $0.15 per share, based on a share price of $109.02. It was a payout ratio of 24.10% compared to their total earnings.
Agilent Technologies Inc. Summary
New York Stock Exchange / A
Healthcare
Medical - Diagnostics & Research
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Checkout Similar Companies
A scored highly on our reportcard. Here are some similar companies and how they performed.
